How to Value a Residential Behavioral Health Facility in 2026

Residential behavioral health — substance abuse treatment and inpatient mental health — sits at the intersection of healthcare and real estate, with a regulatory overlay that makes most buyers nervous. That nervousness is exactly why the operators who understand valuation in this space can command premium exits.

I've advised on transactions across the behavioral health spectrum, from 6-bed sober living homes to 120-bed dual-diagnosis facilities. The valuation dynamics are fundamentally different depending on where you sit on that continuum, and I'll walk through what actually drives value in this space.

The EBITDA Framework: 8-12x for Institutional-Quality Facilities

Residential behavioral health facilities that attract institutional buyers — private equity, hospital systems, national operators — trade at 8-12x EBITDA. That's a wide range, and the spread is driven almost entirely by four factors: bed count, occupancy, payer mix, and accreditation status.

At the lower end (8-9x), you're looking at facilities with 20-40 beds, occupancy in the 70-80% range, heavy Medicaid exposure, and state licensing only. At the upper end (11-12x), it's 60+ beds, 85%+ occupancy, commercial insurance comprising 40%+ of revenue, CARF or Joint Commission accreditation, and a diversified referral network.

Smaller facilities (under 16 beds) typically don't attract institutional buyers and trade closer to 3-5x SDE in private sales. The jump from SDE-based to EBITDA-based valuation as you cross the 16-20 bed threshold can double or triple the enterprise value of the business — a dynamic I've seen transform exit outcomes for operators who expand strategically before selling.

Bed Count: The Foundation of Value

In residential behavioral health, bed count is to valuation what collections are to dental. It's the baseline metric every buyer anchors on because it represents maximum revenue capacity.

The math is straightforward. A 60-bed facility at 85% occupancy with a $750 per bed per day blended rate generates roughly $14M in annual revenue. At a 25-30% EBITDA margin (typical for well-run facilities), that's $3.5-4.2M in EBITDA and a valuation of $28-50M depending on the multiple.

But buyers don't just look at current beds. They look at licensed capacity versus operational capacity. If your state license permits 80 beds but you're only operating 50, that unused capacity is valuable — especially in states where new licenses are difficult to obtain. Certificate of Need (CON) states like Kentucky, Tennessee, and Virginia effectively limit new supply, making existing licensed beds worth a premium.

The flip side is also true. If you're licensed for 30 beds in a non-CON state, the buyer knows a competitor can open across the street tomorrow. That competitive vulnerability compresses multiples.

Occupancy: The Metric That Makes or Breaks Deals

I tell every behavioral health operator the same thing: get occupancy above 80% before you go to market. Below 75%, buyers assume something is structurally wrong — weak referral relationships, quality issues, bad reputation, or poor location. The conversation shifts from "what are we buying" to "what are we fixing," and that always means lower multiples.

Occupancy above 85% triggers a different conversation entirely. Now the buyer sees a capacity-constrained asset with expansion potential. They start modeling additional beds, a new building, or converting unused space — and they're willing to pay a premium for that embedded growth opportunity.

One nuance that less experienced buyers miss: average length of stay (ALOS) affects occupancy economics dramatically. A substance abuse facility with 28-day programs turns beds 13 times per year, while a long-term mental health facility with 90-day stays turns beds 4 times. The 28-day facility has higher admission volume and more marketing cost, but also more opportunities to optimize payer mix on each new admission.

Payer Mix: Why Commercial Insurance Is Worth 3x Medicaid

Nothing drives behavioral health valuations more than payer mix. The economics are stark: a commercial insurance bed day might reimburse $1,200-2,000 depending on the plan and level of care, while Medicaid pays $350-600 in most states. Same bed, same clinical staff, 3-4x the revenue.

Facilities with 40%+ commercial insurance revenue routinely command 10-12x EBITDA. Facilities that are 80%+ Medicaid struggle to get above 7-8x, even with strong occupancy. The reason goes beyond simple revenue per bed day — it's about margin resilience. Medicaid rates are set by the state and can be cut with limited notice. Commercial rates are negotiated and contractual. Buyers prefer the predictability.

Self-pay is a wildcard. Luxury or high-end facilities that command $30,000-60,000 per month in cash pay can achieve extraordinary margins, but buyers discount self-pay revenue because it's volume-sensitive and recession-vulnerable. The ideal mix, in my experience: 40-50% commercial, 30-40% Medicaid/Medicare, 10-20% self-pay.

Accreditation and Licensing: The Non-Negotiable Value Drivers

CARF (Commission on Accreditation of Rehabilitation Facilities) or Joint Commission accreditation is the single biggest binary value driver in behavioral health. Accredited facilities can accept most commercial insurance, qualify for government contracts, and pass the due diligence requirements of institutional buyers. Non-accredited facilities are limited primarily to Medicaid and self-pay.

The valuation impact is significant. I've seen otherwise identical facilities trade at 2-3x multiple point differences based solely on accreditation status. A 40-bed substance abuse facility without CARF might sell at 6-7x EBITDA. The same facility with a clean three-year CARF accreditation sells at 9-10x.

State licensing adds another layer. Every state has different requirements for residential treatment facilities, and the licensing process can take 6-18 months for a new operator. An existing, clean license with no deficiencies is an asset. A license with recent citations, corrective action plans, or conditional status is a liability that will either reduce the purchase price or kill the deal.

Buyers will request your last three survey reports, any complaint investigations, and your corrective action history. Get ahead of this — if you have open deficiencies, resolve them before going to market.

The Real Estate Component

Residential behavioral health is unusual in that the real estate is integral to the business. Unlike a dental practice where the space is interchangeable, a treatment facility is purpose-built (or purpose-converted) with specific zoning approvals, fire safety requirements, and neighborhood acceptance.

Most transactions separate the business value from the real estate, with the property either sold alongside the business or leased back to the buyer. If you own the real estate, expect the business EBITDA multiple to apply to the operating company, with the real estate valued separately at a 7-9% cap rate depending on location and condition.

If you lease, buyers will scrutinize the lease terms ruthlessly. A below-market lease with 10+ years remaining adds value. A lease expiring within 3 years with no renewal option creates material risk — especially since zoning for behavioral health facilities is politically fraught in many municipalities and a new lease at a different location might not be obtainable.

What Destroys Value in Behavioral Health

Clinical quality issues. Any history of adverse events, patient complaints to the state, or negative media coverage will crater your valuation. Buyers conduct extensive clinical due diligence including outcome data review, staff credential verification, and sometimes shadow visits. Clean clinical operations are table stakes.

Key referral concentration. If 30%+ of your admissions come from a single referral source — one interventionist, one hospital system, one EAP contract — you have a concentration risk that sophisticated buyers will discount heavily. Diversified referral networks across hospitals, outpatient providers, interventionists, alumni, and digital channels signal a sustainable admission pipeline.

Staff instability. Licensed clinical staff — psychiatrists, psychologists, LCSWs, LPCs — are extremely hard to recruit in behavioral health. If your clinical team has turned over significantly in the last 12 months, buyers see future recruiting costs and continuity risk. Demonstrate stable tenured clinical staff and you remove a major objection.

Insurance verification and billing problems. Behavioral health has the highest claim denial rate of any healthcare segment. If your days in accounts receivable exceeds 60, or your denial rate is above 15%, buyers will assume a billing infrastructure problem and adjust their offer downward.

Preparing for a Premium Exit

The operators who exit at 10-12x EBITDA almost always spent 2-3 years preparing. Here's what that preparation looks like:

Get CARF accredited if you aren't already. The process takes 12-18 months but the valuation uplift is immediate and significant. Pursue the behavioral health accreditation specific to your service lines.

Push occupancy above 85%. Invest in marketing, referral relationship development, and admission process optimization. Every percentage point of occupancy improvement flows directly to EBITDA and gets multiplied by 8-12x in the valuation.

Shift payer mix toward commercial insurance. Credential with every major commercial carrier in your market, invest in insurance verification staff, and market to populations with employer-sponsored insurance. The revenue per bed day increase is dramatic.

Document everything. Treatment protocols, staff training programs, admission procedures, clinical outcome data, quality improvement initiatives. Institutional buyers need to see a replicable operating model, not a business that runs on tribal knowledge.

The Bottom Line

Residential behavioral health is one of the most active M&A sectors in healthcare, driven by persistent demand, fragmented supply, and institutional capital chasing platform-building opportunities. Facilities that combine strong occupancy, favorable payer mix, CARF accreditation, and clean regulatory history are commanding premium multiples. The operators who understand these dynamics and invest in positioning their facility accordingly are the ones who capture that premium at exit.